| 英文别名： |
2H-Indol-2-one, 6-bromo-3-[(3E)-1,3-dihydro-3-(hydroxyimino)-2H-indol-2-ylidene]-1,3-dihydro-, (3Z)-;BIO;(2'Z,3'E)-6-Bromoindirubin-3'-oxime;2H-Indol-2-one, 6-bromo-3-[(3E)-1,3-dihydro-3-(hydroxyimino)-2H-indol-2-ylidene]-1,3-dihydro-,...;BIO (GSK 3 IX, 6-BIO, 6BIO);BIO,(2'Z,3'E)-6-Bromoindirubin-3'-oxime;GSK 3 Inhibitor IX;GSK-3 Inhibitor IX;6BIO;6-BIO;6-bromoindirubin-3'-monoxime;6-bromoindirubin-3'-oxime;BIOacetoxime;GSK 3 IX;GSK3 Inhibitor IX1;MLS 2052;(2’Z,3’E)-6-Bromoindirubin-3′-oxime;6-bromoindirubin-3-oxime;GSK-3 Inhibitor IX (BIO);(2Z,3E)-6-Bromoindirubin-3'-oxime;InSolution™ GSK-3 Inhibitor IX;(3E)-6'-BROMO-2,3'-BIINDOLE-2',3(1H,1'H)-DIONE 3-OXIME;C16H10BrN3O2;BRW;(2′Z,3′E)-6-Bromoindirubin-3′-oxime;(3Z)-6-bromo-3-[3-(hydroxyamino)indol-2-ylidene]-1H-indol-2-one;(2Z,3E)-6'-bromo-2,3' |
